Each year, an estimated 1 billion people contract seasonal influenza. While most recover without treatment, the illness still causes between 290,000 and 650,000 deaths worldwide annually. Vaccination remains the best protection, but it has its limitations ? with flu shots requiring regular updates to keep pace with viruses that constantly change and new strains that circulate each season.
To begin with, influenza is not a single virus but a group of related viruses that mutate rapidly. Much of this change happens in two proteins on the virus’s surface ? haemagglutinin and neuraminidase ? of which there are numerous varieties. The human immune system recognizes these proteins and produces antibodies to fight them. However, because these structures frequently change, vaccines designed one year may not perfectly match the strains circulating months later. As a result, seasonal flu shots are typically 60% effective at best.
Scientists around the world are working to improve this imperfect solution by creating broader vaccines that could protect against many flu strains for longer periods ? a so-called universal flu vaccine. Around a dozen experimental versions are currently in clinical trials, with many more still in development. Traditional vaccines train the immune system to attack the globular “head” of haemagglutinin, the most visible and abundant protein on the influenza virus’s surface. However, this section mutates quickly. New strategies instead target the more stable “stem” of the protein, which remains largely unchanging across different strains. Early studies suggest this method could help the body produce antibodies capable of recognizing a wide range of influenza viruses.
Researchers are experimenting with various tactics, such as vaccines that expose the immune system to thousands of viral variations or nasal sprays designed to boost immune defenses directly in the lungs. Scientists are also turning to artificial intelligence to improve current vaccines by predicting which strains are most likely to circulate each season.
A truly universal flu vaccine may still be years away. Still, researchers believe better, longer-lasting vaccines could emerge within the next decade, offering stronger protection against one of the world’s most common and recurrent infectious diseases.
Yesel Kang Copy Editor teen/1774255567/1613367750
1. How many people catch influenza annually worldwide?
2. Why must flu vaccines update frequently?
3. What is the goal of universal flu vaccines?
4. Which protein part mutates quickly on influenza viruses?
1. Why are vaccines essential for global health?
2. Would you trust AI-assisted vaccine development?
3. How can science better prevent future pandemics?
4. Should governments invest more in vaccine research?
Each year, an estimated 1 billion people contract seasonal influenza. While most recover without treatment, the illness still causes between 290,000 and 650,000 deaths worldwide annually. Vaccination remains the best protection, but it has its limitations ? with flu shots requiring regular updates to keep pace with viruses that constantly change and new strains that circulate each season.
